Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative NRT in CABG Patients
NCT02918500Phase 4Terminated
- Sponsor
- University of Ottawa Heart Institute
- Start
- Oct 2017
- Primary completion
- Jul 2020
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nicotine patch in nicotine dependence (2 arms), sponsored by University of Ottawa Heart Institute. Primary endpoint: Carbon Monoxide (CO) Confirmed Abstinence at the Time of Surgery. Started Oct 2017; status: terminated.
02
Drugs
nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02918500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918500.